US Bancorp’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $44.7K | Sell |
|
|||||
|
2025
Q1 | $35.9K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $44.8K | Buy |
|
|||||
|
2024
Q2 | $1.11K | Sell |
|
|||||
|
2024
Q1 | $16K | Sell |
|
|||||
|
2023
Q4 | $39.4K | Buy |
|
|||||
|
2023
Q3 | $10.3K | Buy |
|
|||||
|
2023
Q2 | $2.65K | Sell |
|
|||||
|
2023
Q1 | $14.7K | Sell |
|
|||||
|
2022
Q4 | $17.3K | Sell |
|
|||||
|
2022
Q3 | $20K | Buy |
|
|||||
|
2022
Q2 | $16K | Buy |
|
|||||
|
2022
Q1 | $13K | Buy |
|
|||||
|
2021
Q4 | $13K | Buy |
|
|||||
|
2021
Q3 | $8K | Sell |
|
|||||
|
2021
Q2 | $45K | Sell |
|
|||||
|
2021
Q1 | $58K | Buy |
|
|||||
|
2020
Q4 | $41K | Buy |
|
|||||
|
2020
Q3 | $7K | Buy |
|
|||||
|
2020
Q2 | $7K | Sell |
|
|||||
|
2020
Q1 | $11K | Hold |
|
|||||
|
2019
Q4 | $14K | Hold |
|
|||||
|
2019
Q3 | $13K | Hold |
|
|||||
|
2019
Q2 | $19K | Sell |
|
|||||
|
2019
Q1 | $24K | Buy |
|
|||||
|
2018
Q4 | $16K | Sell |
|
|||||
|
2018
Q3 | $27K | Sell |
|
|||||
|
2018
Q2 | $39K | Hold |
|
|||||
|
2018
Q1 | $27K | Hold |
|
|||||
|
2017
Q4 | $20K | Hold |
|
|||||
|
2017
Q3 | $16K | Sell |
|
|||||
|
2017
Q2 | $70K | Hold |
|
|||||
|
2017
Q1 | $60K | Sell |
|
|||||
|
2016
Q4 | $75K | Hold |
|
|||||
|
2016
Q3 | $59K | Sell |
|
|||||
|
2016
Q2 | $120K | Sell |
|
|||||
|
2016
Q1 | $178K | Buy |
|
|||||
|
2015
Q4 | $152K | Sell |
|
|||||
|
2015
Q3 | $246K | Sell |
|
|||||
|
2015
Q2 | $350K | Sell |
|
|||||
|
2015
Q1 | $289K | Sell |
|
|||||
|
2014
Q4 | $1.12M | Buy |
|
|||||
|
2014
Q3 | $566K | Buy |
|
|||||
|
2014
Q2 | $366K | Buy |
|